CEO Pascal Soriot reflects on AstraZeneca's H1 2019 Results

CEO Pascal Soriot reflects on AstraZeneca's H1 2019 ResultsПодробнее

CEO Pascal Soriot reflects on AstraZeneca's H1 2019 Results

Brexit preparations have cost £40 million to £50 million: AstraZeneca CEO | Street Signs EuropeПодробнее

Brexit preparations have cost £40 million to £50 million: AstraZeneca CEO | Street Signs Europe

Full Year 2021 financial results: Pascal Soriot, CEOПодробнее

Full Year 2021 financial results: Pascal Soriot, CEO

AstraZeneca CEO Soriot Speaks on $6.9 Billion Cancer Therapy DealПодробнее

AstraZeneca CEO Soriot Speaks on $6.9 Billion Cancer Therapy Deal

H1 2021 financial results: Pascal Soriot, CEOПодробнее

H1 2021 financial results: Pascal Soriot, CEO

AstraZeneca CEO Pascal Soriot goes one-on-one with Jim CramerПодробнее

AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer

Pascal Soriot thanks our people for their commitment and passionПодробнее

Pascal Soriot thanks our people for their commitment and passion

Full Year 2020 financial results: Pascal SoriotПодробнее

Full Year 2020 financial results: Pascal Soriot

AstraZeneca half-year 2019 Results animationПодробнее

AstraZeneca half-year 2019 Results animation

First-quarter 2020: Delivering strong results, fighting COVID-19Подробнее

First-quarter 2020: Delivering strong results, fighting COVID-19

AstraZeneca CEO Pascal Soriot on progress on pancreatic cancerПодробнее

AstraZeneca CEO Pascal Soriot on progress on pancreatic cancer

Pascal Soriot, CEO, AstraZenecaПодробнее

Pascal Soriot, CEO, AstraZeneca

AstraZeneca financial results, full year 2019Подробнее

AstraZeneca financial results, full year 2019

Pharma industry has a trust issue, AstraZeneca CEO says | CNBC ConversationПодробнее

Pharma industry has a trust issue, AstraZeneca CEO says | CNBC Conversation

Q3 2019 Financial Results - Our employeesПодробнее

Q3 2019 Financial Results - Our employees

AstraZeneca CEO Soriot on Pharmaceuticals in ChinaПодробнее

AstraZeneca CEO Soriot on Pharmaceuticals in China

AstraZeneca CEO: We've increased inventory levels ahead of Brexit | Street Signs EuropeПодробнее

AstraZeneca CEO: We've increased inventory levels ahead of Brexit | Street Signs Europe

The new UK government needs to think long term and fund the NHS and research, AstraZeneca CEO saysПодробнее

The new UK government needs to think long term and fund the NHS and research, AstraZeneca CEO says